In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...